Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Marriott

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medical Microbiology|June 1, 1990
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2D J Payne, M S Marriott, S G Amyes
The Journal of Antimicrobial Chemotherapy|January 1, 1995
TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and functionS K Du Bois, M S Marriott, S G Amyes
European Journal of Biochemistry|August 1, 1993
Protein O-mannosylation in Candida albicans. Determination of the amino acid sequences of peptide acceptors for protein O-mannosyltransferaseA Weston, P M Nassau, C Henly, et al.
FEMS Microbiology Letters|June 1, 1990
Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system)D J Payne, J Hood, M S Marriott, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1987
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in miceP F Troke, R J Andrews, M S Marriott, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro potency and in vivo activity of azolesP F Troke, M S Marriott, K Richardson, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesK Richardson, K W Brammer, M S Marriott, et al.
Journal of General Microbiology|September 1, 1977
Growth characteristics and polyene sensitivity of a fatty acid auxotroph of Candida albicansT Y Koh, M S Marriott, J Taylor, et al.
The Journal of Infectious Diseases|March 1, 1991
No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis cariniiH C Jackson, D Colthurst, V Hancock, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1985
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in miceP F Troke, R J Andrews, K W Brammer, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medical Microbiology|June 1, 1990
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2D J Payne, M S Marriott, S G Amyes
The Journal of Antimicrobial Chemotherapy|January 1, 1995
TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and functionS K Du Bois, M S Marriott, S G Amyes
European Journal of Biochemistry|August 1, 1993
Protein O-mannosylation in Candida albicans. Determination of the amino acid sequences of peptide acceptors for protein O-mannosyltransferaseA Weston, P M Nassau, C Henly, et al.
FEMS Microbiology Letters|June 1, 1990
Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system)D J Payne, J Hood, M S Marriott, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1987
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in miceP F Troke, R J Andrews, M S Marriott, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro potency and in vivo activity of azolesP F Troke, M S Marriott, K Richardson, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytesK Richardson, K W Brammer, M S Marriott, et al.
Journal of General Microbiology|September 1, 1977
Growth characteristics and polyene sensitivity of a fatty acid auxotroph of Candida albicansT Y Koh, M S Marriott, J Taylor, et al.
The Journal of Infectious Diseases|March 1, 1991
No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis cariniiH C Jackson, D Colthurst, V Hancock, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1985
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in miceP F Troke, R J Andrews, K W Brammer, et al.
Pageof 3